University of Cambridge's Alastair Compston wins 2015 John Dystel Prize for MS Research

NewsGuard 100/100 Score

The American Academy of Neurology (AAN) and the National Multiple Sclerosis Society are awarding the 2015 John Dystel Prize for MS Research to Alastair Compston, MBBS, PhD, Professor of Neurology at the University of Cambridge. Compston will receive the award at the Academy's 67th Annual Meeting in Washington, DC, April 18 to 25, 2015. The Annual Meeting is the world's largest gathering of neurologists with more than 12,000 attendees and more than 2,500 scientific presentations on the latest research advancements in brain disease.

The John Dystel Prize recognizes a significant contribution to research in the understanding, treatment or prevention of multiple sclerosis (MS).

Compston's research focuses on the evolution of ideas on the way multiple sclerosis develops. At this year's AAN Annual Meeting, Compston will discuss work in clinical science addressing hypotheses developed in the 1980s that pioneered the development of a highly effective mechanism-based therapy for patients with relapsing-remitting multiple sclerosis.

"The advances in treatment of multiple sclerosis seen in the last 20 years have been remarkable and unmatched by therapies developed for any other neurological disease," said Compston. "I am conscious of the enormous contributions made by many clinicians, scientists and people with multiple sclerosis who enabled the successful outcome of this work."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer